- Home
- HUN vs DYN Comparison
HUN vs DYN Comparison
Compare HUN & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUN
- DYN
- Stock Information
- Founded
- HUN 1970
- DYN 1984
- Country
- HUN United States
- DYN United States
- Employees
- HUN N/A
- DYN N/A
- Industry
- HUN Major Chemicals
- DYN Medicinal Chemicals and Botanical Products
- Sector
- HUN Industrials
- DYN Health Care
- Exchange
- HUN Nasdaq
- DYN Nasdaq
- Market Cap
- HUN 1.8B
- DYN 1.9B
- IPO Year
- HUN 2005
- DYN 2020
- Fundamental
- Price
- HUN $8.46
- DYN $18.88
- Analyst Decision
- HUN Hold
- DYN Strong Buy
- Analyst Count
- HUN 11
- DYN 15
- Target Price
- HUN $10.00
- DYN $36.00
- AVG Volume (30 Days)
- HUN 5.9M
- DYN 3.1M
- Earning Date
- HUN 11-06-2025
- DYN 11-05-2025
- Dividend Yield
- HUN 11.79%
- DYN N/A
- EPS Growth
- HUN N/A
- DYN N/A
- EPS
- HUN N/A
- DYN N/A
- Revenue
- HUN $5,780,000,000.00
- DYN N/A
- Revenue This Year
- HUN N/A
- DYN N/A
- Revenue Next Year
- HUN $4.44
- DYN N/A
- P/E Ratio
- HUN N/A
- DYN N/A
- Revenue Growth
- HUN N/A
- DYN N/A
- 52 Week Low
- HUN $7.30
- DYN $6.36
- 52 Week High
- HUN $20.94
- DYN $35.68
- Technical
- Relative Strength Index (RSI)
- HUN 49.29
- DYN 50.39
- Support Level
- HUN $7.30
- DYN $17.03
- Resistance Level
- HUN $8.70
- DYN $24.25
- Average True Range (ATR)
- HUN 0.43
- DYN 1.63
- MACD
- HUN 0.07
- DYN -0.56
- Stochastic Oscillator
- HUN 53.78
- DYN 24.47
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.